SOPHiA Genetics Stock Forecast, Price & News

SOPHiA Genetics (NASDAQ:SOPH) Frequently Asked Questions

Is SOPHiA Genetics a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SOPHiA Genetics in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SOPHiA Genetics stock.
View analyst ratings for SOPHiA Genetics or view top-rated stocks.

When is SOPHiA Genetics' next earnings date?

SOPHiA Genetics is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for SOPHiA Genetics.

How were SOPHiA Genetics' earnings last quarter?

SOPHiA Genetics SA (NASDAQ:SOPH) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.30) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.38) by $0.08. The business had revenue of $10.36 million for the quarter, compared to analyst estimates of $10.25 million. SOPHiA Genetics had a negative trailing twelve-month return on equity of 44.62% and a negative net margin of 168.10%.
View SOPHiA Genetics' earnings history.

What guidance has SOPHiA Genetics issued on next quarter's earnings?

SOPHiA Genetics issued an update on its FY 2021 earnings guidance on Wednesday, December, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $40 M-, compared to the consensus revenue estimate of $40.14 million.

What price target have analysts set for SOPH?

4 brokerages have issued 1-year price objectives for SOPHiA Genetics' stock. Their forecasts range from $22.00 to $24.00. On average, they anticipate SOPHiA Genetics' share price to reach $23.00 in the next year. This suggests a possible upside of 73.1% from the stock's current price.
View analysts' price targets for SOPHiA Genetics or view top-rated stocks among Wall Street analysts.

Who are some of SOPHiA Genetics' key competitors?

Some companies that are related to SOPHiA Genetics include SpringWorks Therapeutics (SWTX), Sana Biotechnology (SANA), Valneva (VALN), Bavarian Nordic A/S (BVNRY), Relay Therapeutics (RLAY), Recursion Pharmaceuticals (RXRX), Instil Bio (TIL), Kymera Therapeutics (KYMR), Iovance Biotherapeutics (IOVA), ImmunityBio (IBRX), Allogene Therapeutics (ALLO), Ginkgo Bioworks (DNA), Editas Medicine (EDIT), BioCryst Pharmaceuticals (BCRX) and Revolution Medicines (RVMD).
View all of SOPH's competitors.

When did SOPHiA Genetics IPO?

(SOPH) raised $234 million in an IPO on Friday, July 23rd 2021. The company issued 13,000,000 shares at a price of $17.00-$19.00 per share.

What is SOPHiA Genetics' stock symbol?

SOPHiA Genetics trades on the NASDAQ under the ticker symbol "SOPH."

When does the company's lock-up period expire?

SOPHiA Genetics' lock-up period expires on Wednesday, January 19th. SOPHiA Genetics had issued 13,000,000 shares in its initial public offering on July 23rd. The total size of the offering was $234,000,000 based on an initial share price of $18.00. After the end of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

Who are SOPHiA Genetics' major shareholders?

SOPHiA Genetics' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Generation Investment Management LLP (10.72%), Credit Suisse AG (2.97%), Principal Financial Group Inc. (1.30%), Jennison Associates LLC (1.02%), Pura Vida Investments LLC (0.71%) and Millennium Management LLC (0.50%).

Which major investors are buying SOPHiA Genetics stock?

SOPH stock was acquired by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Credit Suisse AG, Principal Financial Group Inc., Jennison Associates LLC, Pura Vida Investments LLC, Millennium Management LLC, BlackRock Inc., and RTW Investments LP.

How do I buy shares of SOPHiA Genetics?

Shares of SOPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SOPHiA Genetics' stock price today?

One share of SOPH stock can currently be purchased for approximately $13.29.

How much money does SOPHiA Genetics make?

SOPHiA Genetics has a market capitalization of $841.76 million and generates $28.40 million in revenue each year.

What is SOPHiA Genetics' official website?

The official website for SOPHiA Genetics is www.sophiagenetics.com.